Collectively, these findings indicate that SEMA3B‐AS1 suppresses CRC angiogenesis by affecting the activation of the VEGF signaling pathway, which is mediated by the SEMA3B–NRP1 axis (Figure 7H). This evidence concerns the gene VEGFA and colorectal carcinoma.